| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/27/2002 | US20020082216 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 06/27/2002 | US20020082215 Administering to nasal cavity of mammal a pharmaceutical composition comprising therapeutically effective amount of insulin-like growth factor-I or biologically active variant thereof |
| 06/27/2002 | US20020082214 Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 06/27/2002 | US20020082213 Administering Orphanin FQ or a pharmacologically active derivative thereof in daily dosage of 0.1 nanograms-0.1 milligrams per kilogram body weight |
| 06/27/2002 | US20020082211 Human presenilin variant |
| 06/27/2002 | US20020082210 Nucleic acid molecules which encode novel ion channel members; medical diagnosis |
| 06/27/2002 | US20020082209 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 06/27/2002 | US20020082208 Mannan binding lectin-associated serine protease-2; serine protease that acts in the MBLectin complement fixation pathway |
| 06/27/2002 | US20020082207 Comprising pancreatic tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, T cells specific for cells expressing such polypeptides |
| 06/27/2002 | US20020082206 Nucleic acids that include open reading frames encoding novel polypeptides; antiinflammatory, antitumor agents |
| 06/27/2002 | US20020082205 Human FGF-23 gene and gene expression products |
| 06/27/2002 | US20020082204 Treatment of allergies, respiratory system disorders by administering therapeutically effective amount of isolated nucleic acid including a sequence encoding a p20 polypeptide to cell of mammal and expressing p20 polypeptide in cell |
| 06/27/2002 | US20020082203 Novel sphingosine kinases |
| 06/27/2002 | US20020082202 Screening methods using ligands of the neutropeptide receptor HFGAN72 |
| 06/27/2002 | US20020082201 And pharmaceutically acceptable surfactant including sodium lauryl sulfate, buffering agent to provide pH of 3.0-7.0, 0.5-10.0 weight percent colloidal silicon dioxide |
| 06/27/2002 | US20020082199 Insoluble insulin compositions |
| 06/27/2002 | US20020082198 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 06/27/2002 | US20020082197 Method for treating a mucus secretion |
| 06/27/2002 | US20020082196 Peptides with physiological activity |
| 06/27/2002 | US20020082195 Novispirins: antimicrobial peptides |
| 06/27/2002 | US20020082194 Drug-metabolizing proteins that are related to the UDP-glucuronosyltransferase drug-metabolizing enzyme subfamily, recombinant DNA molecules and protein production |
| 06/27/2002 | US20020082191 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020082190 Amino acid sequences of the transport proteins encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; brain disorders |
| 06/27/2002 | US20020082189 Amino acid sequences of the kinase peptides encoded by genes within the human genome; isolated peptide and nucleic acid molecules, methods of identifying orthologs, paralogs and modulators of the kinase peptides; anticarcinogenic agents |
| 06/27/2002 | US20020081739 Genetically engineering cells; obtain cell, obtain nucleotide sequences, adhere sequences to sheets, propel sheet into cells, recover transformed cells |
| 06/27/2002 | US20020081734 Modified muteins of erythropoietin derived from in vitro or in vivo expression system of microorganism |
| 06/27/2002 | US20020081723 Respiratory syncytial virus (RSV) fusion protein; treating or preventing RSV infection, as well as for diagnosis of RSV in analytes |
| 06/27/2002 | US20020081722 Nucleotide sequences coding preferential polypeptide for use in treatment and prevention of bacterial infection |
| 06/27/2002 | US20020081720 Receptor activator of NF-kappaB |
| 06/27/2002 | US20020081718 Polypeptide, and a dna sequence to which a protein containing the polypetide binds |
| 06/27/2002 | US20020081705 Human caspase-14 compositions |
| 06/27/2002 | US20020081703 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein |
| 06/27/2002 | US20020081700 Polynucleotide encoding protein for use as tool in evaluating cell and tissue development |
| 06/27/2002 | US20020081699 Human lysophospholipase |
| 06/27/2002 | US20020081695 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 06/27/2002 | US20020081691 Delta 1-pyrroline-5-carboxylate reductase homolog |
| 06/27/2002 | US20020081689 Isolated human dehydrogenase proteins, nucleic acid molecules encoding these human dehydrogenase proteins, and uses thereof |
| 06/27/2002 | US20020081686 Novel antimicrobial therapies |
| 06/27/2002 | US20020081685 Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12 |
| 06/27/2002 | US20020081683 Polypeptide for use in the diagnosis and treatment of psoriasis, infection, asthma and immune and respiratory disorders |
| 06/27/2002 | US20020081682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of bacterial infections |
| 06/27/2002 | US20020081680 Fusion protein for use in the diagnosis and treatment of tumors |
| 06/27/2002 | US20020081679 NARC8 programmed cell-death-associated molecules and uses thereof |
| 06/27/2002 | US20020081672 Nucleotide sequences coding enzymatic polypeptide for use in generation of lysine for foods, medicines and animal nutrients |
| 06/27/2002 | US20020081664 Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 06/27/2002 | US20020081663 Polypeptide for use as wound healing agent |
| 06/27/2002 | US20020081659 Nucleic acids, proteins and antibodies |
| 06/27/2002 | US20020081657 21784, a novel human calcium channel family member and uses thereof |
| 06/27/2002 | US20020081655 Splice variant of mGluR |
| 06/27/2002 | US20020081653 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/27/2002 | US20020081652 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis |
| 06/27/2002 | US20020081651 Nucleotide sequences coding enzymatic polypeptide; for us ein the treatment of atherosclerosis, hypertension, oncogenesis and metastasis, heart disease, Alzheimer's disease, neurofibromatosis amd respiratory disorders |
| 06/27/2002 | US20020081650 Expression vectors coding protein for use in the treatment of cancer, and neovascularization defects |
| 06/27/2002 | US20020081647 Apoptosis inducing molecule ii and methods of use |
| 06/27/2002 | US20020081644 Encoded by a polynucleotide; use as reporter molecule |
| 06/27/2002 | US20020081636 Novel molecules of the card-related protein family and uses thereof |
| 06/27/2002 | US20020081633 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 06/27/2002 | US20020081627 Inhibition of adenovirus replication by product R, A peptide nucleic acid immunomodulator |
| 06/27/2002 | US20020081623 Chemotactic cytokine |
| 06/27/2002 | US20020081609 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/27/2002 | US20020081608 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of cancer |
| 06/27/2002 | US20020081607 Four disulfide core domain-containing (FDCD) polynucleotides, polypeptides, and antibodies |
| 06/27/2002 | US20020081604 Polypeptide for use in the treatment of diagnosis, prevention, and treatment of infectious, developmental, neoplastic, and immunological defects |
| 06/27/2002 | US20020081601 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 06/27/2002 | US20020081599 Nucleotide sequences coding preferential polypeptide for use in cancer therapy |
| 06/27/2002 | US20020081590 Microarray for use in the detection of preferential genes in sample |
| 06/27/2002 | US20020081578 Nucleotide sequences coding preferential polypeptide for as anticarcinogenic agents |
| 06/27/2002 | US20020081577 Synthetic oligonucleotide for use in the prevention of viral disease |
| 06/27/2002 | US20020081576 Antibodies directed against binding-associated epitopes |
| 06/27/2002 | US20020081574 Enzymatic polypeptide for use in the diagnosis, prevention and treatment of viral disease |
| 06/27/2002 | US20020081568 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
| 06/27/2002 | US20020081324 Method of treating aging skin and wrinkles using a combination of growth factors that is commercially prepared or derived from one's own blood |
| 06/27/2002 | US20020081320 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 06/27/2002 | US20020081319 Treating hypothyroidism thereof by local administration to the thyroid gland of a patient |
| 06/27/2002 | US20020081314 Starch and protein from a mixture of embryo bud and seed coat of rice and fruit body of ganoderma lucidum are decomposed by aspergills oryzae with added B vitamins, and the enzyme retain their catalytic activity; prevent autoimmune diabetes |
| 06/27/2002 | US20020081312 For the diagnosis and immunization of humans and animals against gastrointestinal disorders |
| 06/27/2002 | US20020081311 Improving gut barrier function and/or competitively excluding pathogens from binding to and invading epithelial cells; adhesin component derived Lactobacillus species such as L. salivarius |
| 06/27/2002 | US20020081310 Apoptosis-related compounds and their use |
| 06/27/2002 | US20020081306 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists |
| 06/27/2002 | US20020081305 Altering the properties of cells or of particles with menbranes derived from cells by means of lipid-modified proteinaceous molecules |
| 06/27/2002 | US20020081302 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis |
| 06/27/2002 | US20020081299 Hair cell disorders |
| 06/27/2002 | US20020081298 An immunoglobulin or portion thereof linked to a T cell receptor agonist derived from an antigen responsible for an autoimmune disease, capable of undergoing Fc receptor medited ukptake by antigen presenting cells |
| 06/27/2002 | US20020081296 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 06/27/2002 | US20020081295 Virus-like particles for the induction of autoantibodies |
| 06/27/2002 | US20020081294 Co-administering effective amounts of tissue plasminogen actiator (tPA) and ati-CD18 antibody to mammal until about three to five hours after the onset of focal ischemic stroke to increase cerebral blood flow |
| 06/27/2002 | US20020081293 Antibody, homologues, or analogues or fragments, peptide, or peptidomimetic used as serene protease inhibitor (factor D inhibitor) |
| 06/27/2002 | US20020081291 Alpha-bungarotoxin molecules and uses thereof |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | US20020081288 A polypeptide selected from the group consisting of a SOD-4 polypeptide (superoxide dimutase) having a preferred deduced amino acid sequence and fragments, analogs and derivatives encoded by a specific polynucleotide |
| 06/27/2002 | US20020081287 Manganese superoxide dismutase cloning and expression in microorganisms |
| 06/27/2002 | US20020081286 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/27/2002 | US20020081285 Treatment for diabetes |
| 06/27/2002 | US20020081284 Manipulation of arterial-venous identity |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/27/2002 | US20020081277 Methods and compositions for enhancing the immunostimulatory effect of interleukin-12 |
| 06/27/2002 | US20020081276 Gene therapy utilizing hematopoietic stem cells, lymphoid progenitor cells and/or myeloid progenitor cells which are genetically modified to provide a gene that is expressed in these cells and their progency after differentiation |
| 06/27/2002 | US20020081265 Composition for treatment of a bacterial infection of the upper respiratory tract |
| 06/27/2002 | US20020078969 Method for reducing the effect of nicotine addiction and dependancy |
| 06/27/2002 | DE10063433A1 Verwendung von DNA-Reparatur-Enzymen als MMP-1-Inhibitoren The use of DNA repair enzymes as MMP-1 inhibitors |